| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/10/2004 | EP1395669A2 Matrix attachment regions and methods for use thereof |
| 03/10/2004 | EP1395668A1 Processes and vectors for producing transgenic plants |
| 03/10/2004 | EP1395658A2 Nucleic acid and protein sequences of bovine epidermal growth factor |
| 03/10/2004 | EP1395656A2 Human drug metabolizing enzymes |
| 03/10/2004 | EP1395653A2 Polypeptides having cellobiase activity and polynucleotides encoding same |
| 03/10/2004 | EP1395652A2 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 03/10/2004 | EP1395651A2 Biomaterial substrates |
| 03/10/2004 | EP1395650A2 Biomaterial substrates |
| 03/10/2004 | EP1395647A2 A device and method for seed-train expansion of mammalian cells |
| 03/10/2004 | EP1395612A2 Modified recombinase |
| 03/10/2004 | EP1395611A2 Methods and compositions for treating respiratory mucin production associated disease conditions |
| 03/10/2004 | EP1395610A2 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same |
| 03/10/2004 | EP1395609A2 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions |
| 03/10/2004 | EP1395608A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/10/2004 | EP1395607A2 Respiratory syncytial virus |
| 03/10/2004 | EP1395602A2 Novel human potassium channel beta subunit |
| 03/10/2004 | EP1395293A1 Lentiviral vectors encoding clotting factors for gene therapy |
| 03/10/2004 | EP1395278A2 Ocular tear growth factor-like protein |
| 03/10/2004 | EP1395256A2 Prodrugs via acylation with cinnamate |
| 03/10/2004 | EP1395113A2 Use of follistatin to increase muscle mass |
| 03/10/2004 | EP1395111A2 Cloning of transgenic animals comprising artificial chromosomes |
| 03/10/2004 | EP1111991A4 Method of performing transgenesis |
| 03/10/2004 | EP1105469A4 Mammalian transgenesis by intracytoplasmic sperm injection |
| 03/10/2004 | EP0792351B1 Method for producing a human neural cell line |
| 03/10/2004 | EP0651653B1 p53 VACCINE |
| 03/10/2004 | CN1481437A Method for in vitro culture of ovarian follicles |
| 03/10/2004 | CN1481390A Immunomodulatory peptidesderived from heat shock proteins and uses thereof |
| 03/10/2004 | CN1141582C Whole cell selection utilizing azlactone-functional supports |
| 03/10/2004 | CN1141386C Method for cultivating anchorage dependent animal cell by magnetic stabilized fluid bed |
| 03/10/2004 | CN1141385C Notoginseng cell culture method by adding jasmone (acid) compound in culture medium |
| 03/10/2004 | CN1141384C Human marrow-interstitial stem cell and its preparing process |
| 03/10/2004 | CN1141318C Human blood and blood vessel cytopoiesis hormone and its preparation |
| 03/09/2004 | US6703544 Adjustment of seed protein profile |
| 03/09/2004 | US6703539 Method and compositions for modifying levels of secondary metabolic compounds in plants |
| 03/09/2004 | US6703493 Ob (obesity) polypeptides possess an ability to participate in the control of mammalian body weight; use in detection, monitoring, screening, and diagnosis of modulators of weight control; use in treatment/regulation of obesity in mammals |
| 03/09/2004 | US6703486 Peripheral nervous system specific sodium channels |
| 03/09/2004 | US6703485 Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof |
| 03/09/2004 | US6703484 Generating prferential polypeptides; obtain cells, transform with expression vector, culture cell, recover preferential polypeptides |
| 03/09/2004 | US6703238 Methods for expanding antigen-specific T cells |
| 03/09/2004 | US6703232 Contacting human embryo kidney 293 (hek 293) cells with at least two different reoviruses to infect; incubation to reassort; harvesting |
| 03/09/2004 | US6703224 Zcys6: a member of the cystatin superfamily |
| 03/09/2004 | US6703209 Using membrane-bound porcine stem cell factor (pscf) on transfected murine fetal fibroblast cells (sto) feeder cells |
| 03/09/2004 | US6703038 Injectable bone substitute material containing non-ceramic hydroxyapatite cement |
| 03/09/2004 | US6703023 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 03/09/2004 | US6703017 Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures |
| 03/09/2004 | US6703016 Apoptotic bodies, monocyte derived cells containing the same, a process for their preparation and their uses as vaccines |
| 03/04/2004 | WO2004018714A1 Methods and device for decarbonising a steel melt |
| 03/04/2004 | WO2004018683A1 Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine |
| 03/04/2004 | WO2004018681A2 Il-7 drug substance, il- 7 comprising composition, preparation and uses thereof |
| 03/04/2004 | WO2004018680A1 Method of screening tumor antigen |
| 03/04/2004 | WO2004018660A2 Novel lipases and uses thereof |
| 03/04/2004 | WO2004018659A1 Process for the production of temperature-induced tumor cell lysates for use as immunogenic compounds |
| 03/04/2004 | WO2004018658A1 Human bone stem cells |
| 03/04/2004 | WO2004018656A1 Cell culture method and apparatus therefor |
| 03/04/2004 | WO2004018655A2 Method for culturing stem cells |
| 03/04/2004 | WO2004018654A2 Cell culture surface |
| 03/04/2004 | WO2004018653A1 A method of and apparatus for facilitating processes of mammalian cells |
| 03/04/2004 | WO2004018652A2 Method for obtaining diploid, pluripotential stem cells and use thereof |
| 03/04/2004 | WO2004018643A2 Method for regulating dopamine producing cells |
| 03/04/2004 | WO2004018636A2 Methods for modulating transcriptional activation using mint proteins |
| 03/04/2004 | WO2004018620A2 Chitinase encoding dna molecule from cotton expressed preferentially in fibers during secondary cell wall deposition and the corresponding promoter |
| 03/04/2004 | WO2004018619A2 P53 binding t cell receptor molecules and uses thereof |
| 03/04/2004 | WO2004018615A1 Fibrin-containing composition |
| 03/04/2004 | WO2004018002A2 Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells |
| 03/04/2004 | WO2004017978A1 Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy |
| 03/04/2004 | WO2004017972A1 Biologic skin repair and enhancement |
| 03/04/2004 | WO2004017895A2 Formaldehyde-ammonium salt complexes for the stabilization of blood cells |
| 03/04/2004 | WO2004017728A2 Methods |
| 03/04/2004 | WO2004017727A1 A method of treatment and prophylaxis |
| 03/04/2004 | WO2003106674A3 Use of repression blocking sequences in methods for enhancing gene expression |
| 03/04/2004 | WO2003106478A9 ANTIBODIES THAT BIND alphaE INTEGRIN |
| 03/04/2004 | WO2003104476A3 Assay to detect replication competent viruses |
| 03/04/2004 | WO2003103813A3 Materials and reactor systems having humidity and gas control |
| 03/04/2004 | WO2003103720A3 Compositions and methods for the use of bcl-2 transfected neurons |
| 03/04/2004 | WO2003103577A3 Novel recombinant anticoagulant proteins |
| 03/04/2004 | WO2003097871A8 Marker molecules associated with lung tumors |
| 03/04/2004 | WO2003095633A3 Method for the production of cells with increased development potential |
| 03/04/2004 | WO2003095630A3 Bioartificial skin comprising genetically modified fibroblasts |
| 03/04/2004 | WO2003083089A3 Tolerogenic antigen-presenting cells |
| 03/04/2004 | WO2003076604A3 Surgical device for skin therapy or testing |
| 03/04/2004 | WO2003072787A3 Method for detection of leptin receptor ligands |
| 03/04/2004 | WO2003070901A3 Heat stable mutants of starch biosynthesis enzymes |
| 03/04/2004 | WO2003070760A3 Anti-amyloid beta antibodies and their use |
| 03/04/2004 | WO2003065871A3 Methods and compositions for treating hematological disorders |
| 03/04/2004 | WO2003060082A3 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 03/04/2004 | WO2003059276A3 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 03/04/2004 | WO2003057174A3 Methods and compositions for protein expression and purification |
| 03/04/2004 | WO2003055980A3 Il-17 like molecules and uses thereof |
| 03/04/2004 | WO2003054018A3 Anti-tirc7 antibodies in therapy of inflammatory diseases |
| 03/04/2004 | WO2003050254A3 Novel chimeric tnf ligands |
| 03/04/2004 | WO2003047527A3 Variants of adp-glucose pyrophosphorylase affecting phosphate sensitivity and other parameters |
| 03/04/2004 | WO2003042385A3 Gene silencing using sense dna and antisense rna hybrid constructs |
| 03/04/2004 | WO2003027271A3 Regulation of adenovirus dna packaging by iptg |
| 03/04/2004 | WO2003025189A3 A packaging complementation cell-line for sv-40 vectors |
| 03/04/2004 | WO2003018766A9 Self-processing plants and plant parts |
| 03/04/2004 | WO2003000846A3 A novel g protein-coupled receptor, gave 3 |
| 03/04/2004 | WO2002102971A3 Methods of utilizing cultured hematopoietic progenitor cells for inducing immunological tolerance |
| 03/04/2004 | WO2002096263A3 Eb matrix production from fetal tissues and its use for tissue repair |
| 03/04/2004 | WO2002092762A3 Cytokine polypeptides |
| 03/04/2004 | WO2002085944A3 Single chain camelid vhh antibodies, method for their production in a mammal and their uses |